Literature DB >> 3595529

Multiple hormones regulate angiotensinogen messenger ribonucleic acid levels in a rat hepatoma cell line.

E Chang, A J Perlman.   

Abstract

Angiotensinogen is regulated by both hormones and changes in cardiovascular and electrolyte status. We have used the Reuber H35 (H4IIE) rat hepatoma cell line to study the regulation of angiotensinogen mRNA levels by dexamethasone, aldosterone, L-T3, and 17 beta-estradiol. Using the Acc I (1097 basepairs) fragment of our angiotensinogen cDNA clone, we have studied, by Northern and slot blot analysis, the accumulation of angiotensinogen mRNA in this cell culture system. Angiotensinogen mRNA of approximately 1800 bases was identified in these cells. It was identical in size to angiotensinogen mRNA from rat liver. Cells grown in medium containing serum depleted of thyroid and steroid hormones for up to 72 h showed a progressive decrease in angiotensinogen mRNA. Dexamethasone treatment resulted in a time- and dose-dependent increase in angiotensinogen mRNA. The half-maximal response occurred at 10(-9) M dexamethasone, with a maximal response of approximately 4-fold (serum-free conditions). Aldosterone induced a dose-dependent increase in mRNA. Half-maximal levels were obtained at 5 X 10(-8) M. Competition studies using the glucocorticoid antagonist RU38486 (Roussel-UCLAF) confirmed that dexamethasone was acting through the glucocorticoid receptor and suggested that aldosterone was acting through the same receptor. L-T3 treatment caused a dose and time-dependent increase in angiotensinogen mRNA levels. The half-maximal response occurred at 5 X 10(-8) M, and the maximal response was a 2-fold increase. Combined treatment with dexamethasone and L-T3 triiodothyronine resulted in a synergistic increase in angiotensinogen mRNA levels. 17 beta-Estradiol failed to elicit a change in angiotensinogen mRNA levels consistent with the observation that these cells lack estrogen receptors. Our results indicate that hepatic angiotensinogen mRNA levels are regulated in a complex fashion by several hormones. These cells provide a useful system for studying the hormonal regulation of the angiotensinogen gene.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595529     DOI: 10.1210/endo-121-2-513

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Ontogeny of angiotensinogen mRNA and angiotensin II receptors in rat brain and liver.

Authors:  J E Kalinyak; A R Hoffman; A J Perlman
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

2.  Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells.

Authors:  J Aubert; C Darimont; I Safonova; G Ailhaud; R Negrel
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

3.  Control of angiotensinogen production by H4 rat hepatoma cells in serum-free culture.

Authors:  M Togami; D Blazka; J Hayashi
Journal:  In Vitro Cell Dev Biol       Date:  1988-07

4.  Molecular cloning and expression of the rat angiotensinogen gene.

Authors:  J S Chan; A H Chan; Q Jiang; Z R Nie; S LaChance; S Carrière
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

5.  Activation of the silent endogenous cholesterol-7-alpha-hydroxylase gene in rat hepatoma cells: a new complementation group having resistance to 25-hydroxycholesterol.

Authors:  J K Leighton; S Dueland; M S Straka; J Trawick; R A Davis
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

Review 6.  Dynamic regulation of the angiotensinogen gene by DNA methylation, which is influenced by various stimuli experienced in daily life.

Authors:  Masashi Demura; Yosiki Demura; Yoshiyu Takeda; Kiyofumi Saijoh
Journal:  Hypertens Res       Date:  2015-03-26       Impact factor: 3.872

7.  Thyroid hormone receptors and stimulation of angiotensinogen production in HepG2 cells.

Authors:  I A Darby; J Bouhnik; E D Coezy; P Corvol
Journal:  In Vitro Cell Dev Biol       Date:  1991-01

8.  Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.

Authors:  Janice M Paterson; Nicholas M Morton; Catherine Fievet; Christopher J Kenyon; Megan C Holmes; Bart Staels; Jonathan R Seckl; John J Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

9.  A novel role for miR-133a in centrally mediated activation of the renin-angiotensin system in congestive heart failure.

Authors:  Neeru M Sharma; Shyam S Nandi; Hong Zheng; Paras K Mishra; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-10       Impact factor: 4.733

Review 10.  Hypertension, RAS, and gender: what is the role of aminopeptidases?

Authors:  María Jesús Ramírez-Expósito; José Manuel Martínez-Martos
Journal:  Heart Fail Rev       Date:  2008-01-24       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.